FDA approves nivolumab for adjuvant treatment of urothelial carcinoma

Oncology (Cancer)
FDA approves nivolumab for adjuvant treatment of urothelial carcinoma

Source: FDA Center for Drug Evaluation and Research - What's New - August 20, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news